XETRA •
Healthcare •
Drug Manufacturers - General •
Quote as of 05/07/2026 14:55
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeXETRA
Market Capitalization90,218 mln
Float1,087 mln
Earnings Date04/23/2026
EPS
3.96
Solid
P / E
18.65
Moderately valued
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2.45
Borderline
Relative Strength
3
/ 100
Severely lagging
Debt / Equity
0.28
Very low leverage
Business Description
Sanofi is a Paris-based global pharmaceutical company founded in 1994 that develops, manufactures, and sells treatments across a wide range of medical areas, including rare diseases, cancer, neurology, and immune conditions, as well as vaccines for diseases such as hepatitis, rabies, and yellow fever. The company works with numerous partners to advance next-generation therapies, including AI-driven drug discovery, protein degradation treatments, genome editing, and antibody-based medicines. Through these collaborations, Sanofi aims to bring innovative solutions to patients dealing with some of the most complex and difficult-to-treat conditions.